Skip to main navigation
Skip to search
Skip to main content
Prinses Máxima Centrum Home
Nederlands
English
Search content at Prinses Máxima Centrum
Home
Profiles
Research Groups
Equipment
Research output
Prizes
Activities
Press/Media
Trial watch: Dendritic cell-based anticancer therapy
Norma Bloy
, Jonathan Pol
, Fernando Aranda
,
Alexander Eggermont
, Isabelle Cremer
, Wolf Hervé Fridman
, Jitka Fučíková
, Jérôme Galon
, Eric Tartour
, Radek Spisek
, Madhav V. Dhodapkar
, Laurence Zitvogel
, Guido Kroemer
, Lorenzo Galluzzi
Research output
:
Contribution to journal
›
Review article
›
Research
›
peer-review
66
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Trial watch: Dendritic cell-based anticancer therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adaptive Immunity
20%
Anticancer
20%
Anticancer Therapeutics
20%
Anticancer Therapy
100%
Autologous Tumor Cells
20%
Cancer Patients
20%
Carbohydrate Moieties
20%
Cell Surface Receptor
20%
Cell-based
100%
Clinical Development
20%
Dendritic Cells
100%
Immune Response
20%
Immunological Tolerance
20%
Immunomodulatory Drugs (IMiDs)
20%
Immunotherapeutics
20%
In Cancer
20%
Monoclonal Antibody
20%
Patient-derived
20%
Preclinical Development
20%
Provenge
20%
Recent Advances
20%
Sipuleucel-T
20%
Therapeutic Effect
20%
Tumor Antigen
40%
Tumor Cell Lysate
20%
Tumor-specific Immune Response
20%
U.S. Food
20%
Viral Vectors
20%
Medicine and Dentistry
Adaptive Immunity
12%
Autologous Tumor Cell
12%
Cancer Treatment
100%
Carbohydrate Analysis
12%
Cell Receptor
12%
Dendritic Cell
100%
Immune Response
25%
Immunological Tolerance
12%
Malignant Neoplasm
12%
Monoclonal Antibody
12%
Sipuleucel T
25%
Specific Tumor
25%
Therapy Effect
12%
Tumor Antigen
25%
Virus Vector
12%
Immunology and Microbiology
Adaptive Immune System
12%
Cell Lysate
12%
Dendritic Cell
100%
Immune Response
25%
Immune Tolerance
12%
Monoclonal Antibody
12%
Sipuleucel-T
25%
Tumor Antigen
25%
Tumor Cell
12%
Viral Vector
12%